Drug Pipeline

Roflumilast 500 Mcg Oral Tablet Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
5
Recruiting
1
Phase 3
6
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-08 NCT07632846 Effect of Roflumilast as Add-On Therapy in Rheumatoid Arthritis Phase 2 Recruiting
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 2
4
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07352566 Utilization of a Microdevice for Psoriasis and Atopic Dermatitis Psoriasis Not Yet Recruiting
Phase 3
NCT06860958 Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients Depressive Disorder, Major Recruiting
Phase 2
NCT07297602 Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe… Atopic Dermatitis Recruiting
NCT07566351 Effect of Roflumilast and Desloratadine as Add-On Therapy in Patients With Rheumatoid… Rheumatoid Arthritis Recruiting
NCT07632846 Effect of Roflumilast as Add-On Therapy in Rheumatoid Arthritis Rheumatoid Arthritis Recruiting
NCT07543640 EFFICACY OF ROFLUMILAST IN THE TREATMENT OF FLEXURAL AND/OR GENITAL PSORIASIS: A… Flexural Psoriasis (Also Known as Inverse or Intertriginous Psoriasis) and Genital Psoriasis Not Yet Recruiting
Early Phase 1
NCT06643221 Exercise as an Immune Adjuvant for Allogeneic Cell Therapies Leukemia Recruiting
Sponsors Running Roflumilast 500 Mcg Oral Tablet Trials
Horus University (2) University of Arizona (1) Tanta University (1) Nora Mohamed Abdelrazik (1) University of California, San Francisco (1) Eman Raafat Said (1)
Disease Areas
Atopic Dermatitis (2) Psoriasis (2) Rheumatoid Arthritis (2) Leukemia (1) Depression (1)
Get alerts when Roflumilast 500 Mcg Oral Tablet trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free